GPX4 and nonpapillary renal cell carcinoma: We demonstrate that the HIF2α-HILPDA signaling pathway is the main pathway to activate ccRCC, and HIF2α strongly inhibits GPX4 expression by activating downstream proteins (Zou et al., 2019; Courtney et al., 2020; Hoefflin et al., 2020).